WYPH Waypoint Biomedical Holdings Inc (CE)

WayPoint Biomedical, Inc. (Other OTC: WYPH.PK) is pleased to announce a well-respected firm, TRI-STATE Capital (TSC), has upgraded their equity rating on WYPH. This strong upgrade comes at a time when the company is preparing to launch their new high demand Hangover Free topical patch and further expand the US launch of their drink spiking detection kit range. The strong upgrade is also due to WayPoint management securing $7.5 million in initial capital to manufacture, market, and distribute their new JV's SmartCard-based Electronic Medical Records healthcare technology on a global scale. WayPoint CEO, Dennis Shepherd, states, "We are honored to have a quality independent research firm review our overall operations, progress and to provide the resulting upgrade in our stock. This offers further confirmation to our shareholders that our company is headed in the right direction". Mr. Shepherd further comments, "Our upcoming Hangover Free Topical Patch has the potential to quickly generate several million dollars of sales and we anticipate a strong revenue surge from our Drink Detective(TM) drink spiking detection range through our Las Vegas, NV introduction. Las Vegas is a playground for sexual predators and thieves who use these now detectable drugs to perpetuate their crimes. We are introducing both a product and an education/awareness campaign that can help stop this crime." WayPoint has already received orders from two key Canadian Retail Pharmacy groups for their drink spiking detection kit. The company has also confirmed requests for over 10,000 units to be distributed throughout Las Vegas hotels, bars, clubs, nightclubs, and retail stores. Management anticipates accelerated growth throughout 2006 and 2007 due to a robust product pipeline of innovative new products, aggressive marketing, and worldwide expansion. TSC is noted for their work with, account executives, analysts, portfolio managers, institutions, venture capital investors, individual investors and the media. To view the entire independent research report, please click on the attached URL: http://www.otclive.com About WayPoint Biomedical, Inc. WayPoint Biomedical, Inc., a wholly owned subsidiary of WayPoint Biomedical Holdings, Inc. (Other OTC:WYPH), is an innovative biomedical technology firm, specializing in diagnostic tests and devices for screening and monitoring human health, fitness and environment. The Company develops and markets cutting-edge disposable rapid tests that offer both a preliminary diagnostic screen to specific conditions, along with a future path for consumers, medical providers, and first responders to follow regarding their health status or environmental condition. For more information on WayPoint Biomedical visit www.waypointbiomedical.com, www.drinkdetectiveusa.com. Forward-Looking Statements This press release contains forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially.